FMR1 and fragile X syndrome: Group 1 (mGluR1 and mGluR5) are generally postsynaptic in location, couple to Gq, and activate phospholipase C. mGluR5, which signals through FMRP, has been the major target of drug discovery for FXS over the past decade (87).